SEARCH

SEARCH BY CITATION

References

  • 1
    Prescott E, Hippe M, Schnohr P, et al.Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998;316:10431047.
  • 2
    Mannami T, Iso H, Baba S, et al; Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Disease Group. Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: the JPHC Study Cohort I. Stroke. 2004;35:12481253.
  • 3
    Hozawa A, Okamura T, Murakami Y, et al; NIPPON DATA80 Research Group. Joint impact of smoking and hypertension on cardiovascular disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year follow-up. Hypertens Res. 2007;30:11691175.
  • 4
    Honjo K, Iso H, Tsugane S, et al.The effects of smoking and smoking cessation on mortality from cardiovascular disease among Japanese: pooled analysis of three large-scale cohort studies in Japan. Tob Control.2010;19:5057.
  • 5
    Hozawa A. Attributable fractions of risk factors for cardiovascular diseases. J Epidemiol.2011;21:8186.
  • 6
    Verdecchia P, Schillaci G, Borgioni C, et al.Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension. J Hypertens. 1995;13:12091215.
  • 7
    Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension. 1999;33:586590.
  • 8
    Lowe GD, Yarnell JW, Rumley A, et al.C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?Arterioscler Thromb Vasc Biol. 2001;21:603610.
  • 9
    Newby DE, McLeod AL, Uren NG, et al.Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation. 2001;103:19361941.
  • 10
    MacCallum PK. Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers. Proc Am Thorac Soc.2005;2:3443.
  • 11
    Yanbaeva DG, Dentener MA, Creutzberg EC, et al.Systemic effects of smoking. Chest. 2007;131:15571566.
  • 12
    Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 2010;34:J258J265.
  • 13
    Kario K, Pickering TG, Umeda Y, et al.Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:14011406.
  • 14
    Kario K, Yano Y, Matsuo T, et al.Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients. Eur Heart J. 2011;32:574580.
  • 15
    Matsuo S, Imai E, Horio M, et al; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982992.
  • 16
    Blann AD, McCollum CN. von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis. Blood Coagul Fibrinolysis. 1999;10:375380.
  • 17
    Mikkelsen KL, Wiinberg N, Høegholm A, et al.Smoking related to 24-h ambulatory blood pressure and heart rate: a study in 352 normotensive Danish subjects. Am J Hypertens. 1997;10:483491.
  • 18
    Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J. 1986;111:932940.
  • 19
    Lee DH, Ha MH, Kim JR, Jacobs DR Jr. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study. Hypertension. 2001;37:194198.
  • 20
    Bowman TS, Gaziano JM, Buring JE, Sesso HD. A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol. 2007;5:20852092.
  • 21
    Tachmes L, Fernandez RJ, Sackner MA. Hemodynamic effects of smoking cigarettes of high and low nicotine content. Chest. 1978;74:243246.
  • 22
    Alessi MC, Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol. 2006;26:22002207.
  • 23
    Scarabin PY, Plu-Bureau G, Bara L, et al.Haemostatic variables and menopausal status: influence of hormone replacement therapy. Thromb Haemost. 1993;70:584587.
  • 24
    Gebara OC, Mittleman MA, Sutherland P, et al.Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation. 1995;91:19521958.
  • 25
    Baumert J, Ladwig KH, Ruf E, et al; KORA Investigators. Determinants of heavy cigarette smoking: are there differences in men and women? Results from the population-based MONICA/KORA Augsburg surveys. Nicotine Tob Res. 2010;12:12201227.
  • 26
    Chrusciel P, Goch A, Banach M, et al.Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases. Med Sci Monit. 2009;15:RA203RA208.